ML21095A224

Shine Medical Technologies, LLC, Revisions to Final Safety Analysis Report, Chapter 16, Other License Considerations

ML21095A224
Person / Time
Site:	SHINE Medical Technologies
Issue date:	03/23/2021
From:	SHINE Medical Technologies
To:	Office of Nuclear Reactor Regulation
Shared Package
ML21095A241	List: ML21095A214 ML21095A215 ML21095A216 ML21095A217 ML21095A218 ML21095A219 ML21095A220 ML21095A221 ML21095A222 ML21095A223 ML21095A224 ML21095A225 ML21095A226 ML21095A227 ML21095A228 ML21095A229 ML21095A230 ML21095A231 ML21095A232 ML21095A233 ML21095A234 ML21095A235 ML21095A236
References
2021-SMT-0032
Download: ML21095A224 (6)

Text

Chapter 16 - Other License Considerations Table of Contents CHAPTER 16 OTHER LICENSE CONSIDERATIONS TABLE OF CONTENTS Section Title Page 16.1 PRIOR USE OF FACILITY COMPONENTS ....................................................... 16.1-1 16.2 MEDICAL USE OF THE FACILITY ..................................................................... 16.2-1 SHINE Medical Technologies 16-i Rev. 0

Chapter 16 - Other License Considerations List of Tables LIST OF TABLES Number Title None SHINE Medical Technologies 16-ii Rev. 0

Chapter 16 - Other License Considerations List of Figures LIST OF FIGURES Number Title None SHINE Medical Technologies 16-iii Rev. 0

Chapter 16 - Other License Considerations Acronyms and Abbreviations ACRONYMS AND ABBREVIATIONS Acronym/Abbreviation Definition None SHINE Medical Technologies 16-iY Rev. 0

Chapter 16 - Other License Considerations Prior Use of Facility Components CHAPTER 16 - OTHER LICENSE CONSIDERATIONS 16.1 PRIOR USE OF FACILITY COMPONENTS The SHINE facility utilizes new and appropriately-qualified components and systems to conduct production operations. Discussions regarding used components and systems are not applicable to the SHINE facility.

SHINE Medical Technologies 16.1-1 Rev. 0

Chapter 16 - Other License Considerations Medical Use of the Facility 16.2 MEDICAL USE OF THE FACILITY The SHINE facility does not contain equipment or facilities associated with direct medical administration of radioisotopes or other radiation-based therapies. Therefore, discussions involving medical use of the SHINE facility are not applicable.

SHINE Medical Technologies 16.2-1 Rev. 0